|
|
||||||||
Vol. 54, Issue 1, 129-158, March 2002
Viszeral und Transplantationschirurgie, Medizinische Hochschule Hannover (H.S., J.K.); and Center of Drug Research and Medical Biotechnology, Fraunhofer Institut für Toxikologie und Aerosolforschung, Hannover, Germany (J.B.)
Abstract
I. Transcription Factors and Gene Regulation
A. Principal Mechanisms
B. Chromatin Higher Order Structure and Transcription Factor Function
1. ATP-Utilizing Chromatin Remodeling Complexes: Switch/Sucrose Nonfermenting and Relatives.
a. Switch/Sucrose Nonfermenting Subunits and Their Interaction with DNA.
b. Switch/Sucrose Nonfermenting Complex and Cell Cycle Control: Impact on Liver Regeneration?
c. Components of the Switch/Sucrose Nonfermenting Complex as Cofactors for Nuclear Receptors.
d. Further Multiprotein Complexes with Homology to the Switch/Sucrose Nonfermenting ATPase.
2. Chromatin Modification: Reversible Acetylation of Histone Lysines.
3. Chromatin Modification: Reversible Phosphorylation of Histone Serines and Threonines.
4. Chromatin Modification: Reversible Ubiquitination of Histone Lysines.
5. Chromatin Modification: Reversible DNA Methylation.
C. Epigenetics
D. Position-Effect Variegation
E. Formation of the Multiprotein Complex
II. Classification of Liver-Enriched Transcription Factors
A. DNA-Binding Domain of Hepatocyte Nuclear Factor-1
B. DNA-Binding Domain of Hepatocyte Nuclear Factor-3
C. DNA-Binding Domain of Hepatocyte Nuclear Factor-4
D. DNA-Binding Domain of Hepatocyte Nuclear Factor-6
E. DNA-Binding Domain of CCAAT/Enhancer-Binding Proteins
III. Molecular Regulation of Liver Function
A. Liver-Specific Gene Expression
B. Liver-Enriched Transcription Factors
IV. Hepatocyte Nuclear Factors
A. The Hepatocyte Nuclear Factor-1 Family
1. Dimerization Cofactor of Hepatocyte Nuclear Factor-1and Liver-Specific Gene Expression.
B. The Hepatocyte Nuclear Factor-3 Subfamily
C. The Hepatocyte Nuclear Factor-4 Subfamily
1. The Structure and Domains of Hepatocyte Nuclear Factor-4.
2. The Relevance of Hepatocyte Nuclear Factor-4 Splice Variants.
3. Homo- and Heterodimerization of Hepatocyte Nuclear Factor-4 Proteins.
4. Regulation of Hepatocyte Nuclear Factor-4 Function by Phosphorylation.
5. Agonistic and Antagonistic Ligands for the Nuclear Receptor Hepatocyte Nuclear Factor-4.
6. Acetylation of Nucleosomal Histones and Hepatocyte Nuclear Factor-4 by cAMP Response Element-Binding Protein.
7. Chicken Ovalbumin Upstream Promoter-Transcription Factors and Hepatocyte Nuclear Factor-4: Cooperation and Competition.
D. Hepatocyte Nuclear Factor-6
1. Splice Variants of Hepatocyte Nuclear Factor-6.
2. Hepatocyte Nuclear Factor-6 in Development.
3. Regulation of Hepatocyte Nuclear Factor-6 Expression by Growth Hormone.
4. Inhibitory Protein-Protein Interaction between Hepatocyte Nuclear Factor-6 and a Nuclear Receptor.
E. Coactivators for Hepatocyte Nuclear Factor-1 and Hepatocyte Nuclear Factor-4
F. The Hepatocyte Nuclear Factor Network and Tissue-Specific Gene Expression
1. Hepatocyte Nuclear Factor-1 Regulates Hepatocyte Nuclear Factor-4Expression.
2. Hepatocyte Nuclear Factor-1and Hepatocyte Nuclear Factor-4 Regulate Hepatocyte Nuclear Factor-1
Expression.
3. Hepatocyte Nuclear Factor-6, OC-2, Hepatocyte Nuclear Factor-3, and CCAAT/Enhancer-Binding Proteins Regulate Hepatocyte Nuclear Factor-3
Expression.
4. Hepatocyte Nuclear Factor-1Regulates Hepatocyte Nuclear Factor-3
in the Liver.
5. Competition and Cooperation ("Coopetition") between Hepatocyte Nuclear Factor-3and Hepatocyte Nuclear Factor-3
.
G. Human Disease Due to Mutations in Hepatocyte Nuclear Factors
H. Evidence from Knockout Experiments
I. Lack of Confirmation for Existence of Hepatocyte Nuclear Factor-5
V. Challenges for the Future
Acknowledgments
References
| |
Abstract |
|---|
|
|
|---|
Numerous studies have established the pivotal role of liver-enriched transcription factors in organ development and cellular function, and there is conclusive evidence for transcription factors to act in concert in liver-specific gene expression. During organ development and in progenitor cells the timely expression of certain transcription factors is necessary for cellular differentiation, and there is overwhelming evidence for hierarchical and cooperative principles in a networked environment of transcription factors. The search for molecular switches that control stem cell imprinting and liver-specific functions has lead to the discovery of many interactions between such different molecules as transcription factors, coactivators, corepressors, enzymes, DNA, and RNA. Many of these interactions either repress or activate liver-specific gene expression. It thus can be demonstrated that specific mutational changes in liver-enriched transcription factors lead to altered intermolecular interactions with the consequence of human disease. This review provides an overview of our current knowledge about liver-enriched transcription factors and their role in liver function and development. We review the basic principles of gene transcription, the role of liver-enriched transcription factors in liver gene regulation, and the classification of transcription factors by their DNA-binding domains.
| |
I. Transcription Factors and Gene Regulation |
|---|
|
|
|---|
A. Principal Mechanisms
Transcription factors are trans-acting
DNA-binding proteins that bind to a specific cis-acting DNA
sequence within the regulatory element of a gene. Usually, control
regions can be found upstream of the start site of transcription,
although in some cases binding occurs within the coding region.
Transcription factors bound to their cognate cis-acting DNA
sequence interact with the transcriptional machinery and enable
selective gene expression and regulation. Frequently, this process
is governed by the binding of many different proteins to cognate
DNA-binding sites, which enables combinatorial control of gene
expression. An additional level of complexity is provided by
protein-protein interactions between transcription factors and
coactivators or corepressors. Together with the transcriptional machinery, these proteins form a multiprotein complex that enables regulated mRNA synthesis (for review see Pabo and Sauer, 1992
; Giordano
and Avantaggiati, 1999
; Klug, 1999
; Wolberger, 1999
; Goodman and
Smolik, 2000
).
Efficient gene transcription requires a permissive chromatin
environment for successful interaction between the
trans-acting transcription factors of the multiprotein
complex and the respective cis-acting target DNA template of
the nucleosome core particle. Therefore, the modulation of chromatin
structure with its effects on gene transcription represents a key
mechanism for transcriptional repression, derepression, and
transcriptional activation. In the following sections we briefly
summarize some of the fundamental mechanisms in the formation of the
multiprotein complex to provide newfound knowledge on gene
transcription and liver-enriched transcription factors, and we
deliberately exclude aspects of DNA repair and DNA miscoding, which
have been reviewed elsewhere (Krokan et al., 2000
; Thompson and Schild,
2001
).
B. Chromatin Higher Order Structure and Transcription Factor Function
Chromatin is composed of a histone octamer, the DNA of the
nucleosome core particle, and the linker DNA. The nucleosome core particle is formed by about 160 bp1 of DNA wrapped
around an octamer composed of two copies of each of the four histones
H2A, H2B, H3, and H4. Within the nucleosome core particle an
(H3)2(H4)2 tetramer, as
well as an H2A-H2B dimer, could be distinguished. These histone
oligomers could be recombined with DNA in vitro to generate the
characteristic X-ray diffraction pattern of chromatin (Kornberg and
Thomas, 1974
; Kornberg and Lorch, 1999
). Figure
1 shows the basic entities that form
chromatin, and Fig. 2 shows a schematic
transection of the nucleosome core particle based on X-ray findings by
Luger et al. (1997)
. X-Ray and electron crystallography revealed the
coiling of DNA in left-handed superhelical turns around the histones
(Finch et al., 1977
). Crystallographic analysis of the nucleosome
showed that the histones form a left-handed protein superhelix matching
that of the DNA in the nucleosome core particle (Klug et al., 1980
;
Arents and Moudrianakis, 1995
; Kornberg and Lorch, 1999
).
|
|
The human genome consists of 2.91 billion base pairs, which would be
theoretically about 1.8 m long if stretched out as one long chain
(Venter et al., 2001
). DNA is organized into chromatin to achieve the
required high level of compaction to pack this DNA into a nucleus with
a diameter less than 6 nm (Lewin, 1994
). The orderly packaging of DNA
in the nucleus plays an important role in the functional aspects of
gene regulation. Only a small percentage of chromatin is made available
to transcription factors and the transcriptional machinery, whereas the
remainder of the genome is in a state that is essentially inaccessible
to the RNA polymerases. ATP-dependent chromatin remodeling as well as
chromatin modifications by acetylation of lysines, DNA methylation,
phosphorylation of serines and threonines, and ubiquitination of
lysines play key roles in altering chromatin higher order structure and
function (Bradbury, 1992
; Shilatifard, 1998
; Giordano and Avantaggiati, 1999
; Spencer and Davie, 1999
; Stein et al., 1999
). Acetylations and
phosphorylations markedly affect the charge densities of well defined,
very basic N- and C-terminal domains of histones (for details see also
Fig. 2), whereas ubiquitination adds a bulky globular protein,
ubiquitin, to lysines in the C-terminal tails of H2A and H2B (for
review see Bradbury, 1992
; Bird and Wolffe, 1999
; Kornberg and Lorch,
1999
).
New findings on ATP-dependent chromatin remodeling as well as chromatin modifications by covalent acetylation, phosphorylation, ubiquitination, and DNA methylation demonstrate the importance of these alterations for the regulation of many genes, although their precise role in liver gene expression remains largely unknown. The following sections provide an overview of recent data and hopefully stimulate further investigations on the role of chromatin remodeling and chromatin modifications in liver function, liver regeneration, and liver development. Additionally, the concepts of epigenetics and position-effect variegation (PEV), and their possible impact on gene transcription and expression, are discussed, because these concepts are of fundamental importance in gene transcription but are widely neglected in molecular investigations of liver-specific gene expression.
1. ATP-Utilizing Chromatin Remodeling Complexes: Switch/Sucrose
Nonfermenting and Relatives.
The activation of a gene requires
accessibility for transcription factors, activators, coactivators, and
transcription machinery to the various regulatory regions. Several
ATP-consuming chromatin remodeling complexes have been identified that
enable gene activation by altering the stable structure of nucleosomes
(for review see Devine et al., 1999
; Muchardt and Yaniv, 1999
; Wade and
Wolffe, 1999
; Tyler and Kadonga, 1999
; Sudarsanam and Winston, 2000
).
/
) showed increased hepatocyte
proliferation in the adult. In addition, embryonic fibroblasts isolated
from the brm
/
mice showed defects in
G1-checkpoint controls. In culture these cells
fail to arrest at confluency. This lack of contact inhibition can be
correlated with a lack of induction of the CDK inhibitor p27 at
confluency (Reyes et al., 19982. Chromatin Modification: Reversible Acetylation of Histone
Lysines.
Expressed genes are located in highly acetylated
chromatin. The acetylation status of nucleosomes is regulated by a
group of enzymes, histone acetyltransferases (HATs) and HDACs. Examples of acetylation sites of histones H3 and H4 are shown in Fig. 2. Both
groups of enzymes contain numerous family members, most of which have
been highly conserved during evolution. The noncatalytic components of
these complexes can either target the catalytic unit to specific sites
of the genome or regulate its enzymatic specificity. DNA methylation
and histone acetylation have also been linked together, whereby
methylation is used to direct gene repression through a histone
deacetylase complex (Gray et al., 1999
) (see also Fig.
3).
|
-estradiol treatment of the human
breast cancer cell line MCF-7 causes a rapid and dramatic increase of
acetylation of histones at the promoter of 17
-estradiol receptor
target genes including pS2, cathepsin D, c-Myc, and EB1. Surprisingly
this acetylation seems to be a transient phenomenon despite the
continuous presence of hormone. It was found that the p160 coactivators
such as the acetylase SRC-3 can be acetylated by p300/CBP and that such
acetylation disrupts hormone receptor-coactivator interaction. These
findings show the possible role of histone acetylation in gene
activation and the possible role of acetylase protein acetylation in
transcriptional attenuation (Chen et al., 19993. Chromatin Modification: Reversible Phosphorylation of Histone
Serines and Threonines.
Histone H1 and H3 phosphorylations
correlate with the process of chromosome condensation. The subunits of
histone H1 kinase have now been shown to be cyclins and the p34CDC2
kinase product of the cell cycle control gene CDC2. It is probable that
all of the processes that control chromosome structure and function
relationships are also involved in the control of the cell cycle
(Bradbury, 1992
; Spencer and Davie, 1999
).
4. Chromatin Modification: Reversible Ubiquitination of Histone
Lysines.
Ubiquitin-dependent proteolytic pathways are largely
responsible for selective protein turnover in the cytosol of
eukaryotes. Although ubiquitinated histones are present in substantial
levels in vertebrate cells, the roles they play in specific biological processes and the cellular factors that regulate this modification are
not well characterized. Ubiquitinated H2B (uH2B) has been identified in
the yeast S. cerevisiae, and mutation of the conserved ubiquitination site could confer defects in mitotic cell growth and
meiosis. uH2B was not detected in rad6 mutants, which are defective for
the ubiquitin-conjugating enzyme Ubc2, thus identifying Rad6 as the
major cellular activity that ubiquitinates H2B in yeast (Robzyk et al.,
2000
).
5. Chromatin Modification: Reversible DNA
Methylation.
Cytosine residues in the sequence 5'CpG
(cytosine-guanine) are often postsynthetically methylated in animal
genomes. The methyl-CpG-binding proteins MeCP1 and MeCP2 interact
specifically with methylated DNA and mediate transcriptional
repression. MeCP2 is an abundant nuclear protein that is essential for
mouse embryogenesis (Nan et al., 1998
). MeCP2 binds tightly to
chromosomes in a methylation-dependent manner. It contains a
transcriptional-repression domain that can function at a distance in
vitro and in vivo. A region of MeCP2 that localizes with the
transcriptional-repression domain associates with a corepressor complex
containing the transcriptional repressor mSin3A and histone
deacetylases (see Fig. 3). Transcriptional repression in vivo is
relieved by the deacetylase inhibitor trichostatin A, indicating that
deacetylation of histones (and/or of other proteins) is an essential
component of this repression mechanism. Two global mechanisms of gene
regulation, DNA methylation and histone deacetylation, can be linked by
MeCP2 (Nan et al., 1998
).
|
C. Epigenetics
The inheritance of information during cell replication on the
basis of gene expression levels is known as epigenetics, as opposed to
genetics, which refers to information inherited on the basis of gene
sequence. Enzymatic methylation of the C-5 position of cytosine
residues can effect epigenetic inheritance by altering the expression
of genes and by transmission of DNA methylation patterns through cell
division (Bird and Wolffe, 1999
; Jones and Laird, 1999
; Wolffe and
Matzke, 1999
). Epigenetic control of gene expression can be considered
from the standpoint of normal development, which requires stable
repression of genes not required in specific cell types (Wolffe and
Matzke, 1999
). Interactions between repeated DNA sequences can trigger
the formation and the transmission of inactive genetic states and DNA
modifications. Methylation induced by DNA repeats can template
chromatin modifications and transcriptional repression by MeCP2 binding
to methylated CpG with subsequent recruitment of histone deacetylase
(Nan et al., 1998
; Jones and Laird, 1999
) (see also Fig. 3).
D. Position-Effect Variegation
The chromosomes of most higher eukaryotes consist of distinct
regions that are cytologically distinguishable owing to differences in
condensation. In a typical chromosome, heterochromatin differs from
euchromatin in sequence composition, function, and cytological appearance and is predominantly located in the pericentric region. The
DNA of heterochromatin consists almost entirely of repetitive sequences
and encodes relatively few genes. In Drosophila, genes juxtaposed to heterochromatin are frequently inactivated, a phenomenon known as PEV. Inactivation is believed to result from the spreading of
the heterochromatin state along the chromosome (Dorer and Henikoff 1994
, 1997
). The extent of PEV spreading may vary from cell to cell,
producing mosaic expression of nearby genes. In contrast with the
growing understanding of transacting factors, little is known of
cis-acting requirements for heterochromatin formation and
PEV. Experiments with Drosophila using a
mini-white reporter gene, a commonly used eye color marker
in Drosophila P transposons, and PEV to explore
the requirements for heterochromatin formation revealed that variegated
expression of mini-white occurs when it is present in repeat
arrays. Variegation was particularly strong for repeated transposons at
a euchromatic site near heterochromatin, but also resulted from repeats
at a site distant from heterochromatin (Dorer and Henikoff, 1994
).
Inactivation strengthened with increasing copy number, a phenomenon
that can also be observed for the transgene in numerous transgenic
animals and plants (Dorer and Henikoff, 1997
; Garrick et al., 1998
).
Experiments using the lox/Cre system of site-specific recombination to
generate transgenic mouse lines showed that the reduction in copy
number results in a methylation at the transgene locus (Garrick et al.,
1998
).
E. Formation of the Multiprotein Complex
The expression of any gene is accomplished primarily through the
interaction of protein transcription factors with characteristic nucleotide sequences located in the control regions of the gene, which
are most commonly located near to, or upstream from, the actual coding
region. The binding of a set of such factors, or regulatory proteins,
acts as a molecular switch for the activation of the RNA polymerase II
(RNA pol II) and other components of the transcriptional machinery,
which are common to all genes. The supply of a particular combination
of such transcription factors ensures that a gene is switched on in the
right cell or tissue and at the right time (Duncan et al., 1998
; Klug,
1999
).
Transcription initiation by RNA pol II requires interaction between
cis-acting promoter elements and trans-acting
factors. The eukaryotic promoter consists of core elements, which
include the TATA and CAAT box and other DNA sequences that define
transcription start sites, and regulatory elements, which either
enhance or repress transcription in a gene-specific manner. The core
promoter is the site for assembly of the transcription preinitiation
complex, which includes RNA pol II and the general transcription
factors TBP, transcription factor IIB (TFIIB), TFIIE, TFIIF, and TFIIH (for review see Roeder, 1996
; Hampsey, 1998
; Shilatifard, 1998
).
Regulatory elements bind gene-specific factors, which affect the rate
of transcription by interacting, either directly or indirectly, with
components of the general transcriptional machinery. A third class of
transcription factors, termed coactivators, is not required for basal
transcription in vitro but often mediates activation by a broad
spectrum of activators. Accordingly, coactivators are neither
gene-specific nor general transcription factors, although gene-specific
coactivators have been described in metazoan systems including humans.
Transcriptional repressors include both gene-specific and general
factors. Similar to coactivators, general transcriptional repressors
affect the expression of a broad spectrum of genes yet do not repress
all genes. General repressors either act through the core
transcriptional machinery or are histone-related and presumably affect
chromatin function, thus preventing RNA transcription ( Chang and
Jaehning, 1997
; Hampsey, 1998
; Yamaguchi et al., 1998
).
Figure 5 depicts a schematic model on the
formation of the multiprotein complex within the promoter region of a
gene. In this model acetylated chromatin is made accessible for
transcription factors (DNA-binding transactivators) in the control
region (promoter regions and enhancer-binding sites) of the respective
gene by ATP-dependent chromatin remodeling complexes. After
transcription factor binding, the RNA polymerase II, general initiation
factors, and mediators bind at the promoter region. Then RNA polymerase II elongation factors bind additionally to the multiprotein complex to
enable mRNA transcription. In this process extensive protein-protein interactions occur that enable the fine tuning of an orchestrated regulation of gene transcription (for review see Roeder, 1996
; Hampsey,
1998
; Shilatifard, 1998
; Wolberger, 1999
).
|
| |
II. Classification of Liver-Enriched Transcription Factors |
|---|
|
|
|---|
Transcription factors achieve recognition of the DNA-binding site
through protein-DNA and protein-protein interactions via discrete
substructures or protein domains that serve binding to DNA. The
DNA-binding motifs of transcription factors contain characteristic amino acid sequences and form characteristic three-dimensional structures that allow the classification of different types of transcription factors. The three-dimensional structure of these DNA-binding motifs leads to DNA sequence-specific DNA binding through
the formation of hydrogen bonds and Van der Waals contacts (Pabo and
Sauer 1992
; Klug, 1999
).
A. DNA-Binding Domain of Hepatocyte Nuclear Factor-1
The first DNA-binding motif identified in X-ray crystallographic
studies is the helix-turn-helix (HTH) motif (Wintjens and Rooman,
1996
). POU domain transcription factors have two separate helix-turn-helix DNA-binding subdomains, the POU homeodomain (POUhd) and the POU-specific domain (POUs). Each subdomain recognizes a
specific subsite of 4 or 5 bp in the octamer recognition sequence (Van
Leeuwen et al., 1997
). The POU domain family of transcription factors
was defined after the observation that the products of three mammalian
genes, Pit-1, Oct-1, and Oct-2, and the protein encoded by the
Caenorhabditis elegans gene unc-86, shared a region of
homology, known as the POU domain (Schonemann et al., 1998
).
Molecular characterization of the genes whose sequence alterations
cause impressive phenotypes in the fruit fly, Drosophila melanogaster, has led to the identification of the human homeobox genes, also referred to as the HOX genes and defined as "master genes" for their crucial role in embryogenesis (McGinnis and
Krumlauf, 1992
). They all share a homeobox region, known as a 180-bp
highly conserved sequence encoding a 60-amino acid DNA-binding domain, also called the "homeodomain", conferring to the resulting proteins the ability to act as transcription factors (Gehring et al., 1994
; Chariot et al., 1999
). The 39 human HOX genes are organized in four
distinct clusters (loci A, B, C, and D) and can be aligned on the basis
of homology within the homeobox to define paralogs (Acampora et al.,
1989
; Scott, 1992
). Besides a critical involvement in cell phenotype
determination along the anterior-posterior axis during embryonic
development, the HOX genes also play a key role in differentiation and
tumoral development (Chariot et al., 1999
; Cillo et al., 1999
; Morata
and Sanchez-Herrero, 1999
).
The liver-enriched transcription factor hepatocyte nuclear
factor-1 (HNF-1) contains a variant homeodomain and shares homeodomain, as well as short acidic and basic sequences, with the POU family of
transcriptional activators (Baumhueter et al., 1990
). HNF-1 is composed
of HNF-1
or HNF-1
homo- or heterodimers (Song et al., 1998
).
B. DNA-Binding Domain of Hepatocyte Nuclear Factor-3
The hepatocyte nuclear factor-3 (HNF-3)/fork head (fkh)
family contains a large number of transcription factors and folds into
a winged helix motif. Despite having almost invariable amino acid
sequences in their principal DNA-binding helices, HNF-3/fkh proteins
show a wide diversity of sequence-specific binding. Previous studies of
chimeric HNF-3/fkh proteins demonstrated that the binding specificity
is primarily influenced by a region directly adjacent to the binding
helix (Marsden et al., 1998
; Jin et al., 1999
). In NMR and X-ray
crystallographic studies it is found that in comparison with HNF-3, the
HNF-3/fork head (fkh) family member Genesis contains an extra small
helix directly prior to the N terminus of the primary DNA contact
helix. Due to the insertion of this helix, a shorter and slightly
repositioned primary DNA contact helix is observed, which is believed
to lead to the DNA-binding specificity differences among various family
members (Marsden et al., 1998
).
C. DNA-Binding Domain of Hepatocyte Nuclear Factor-4
The liver-enriched transcription factor hepatocyte nuclear
factor-4 (HNF-4) belongs to the group of zinc finger proteins and is
frequently seen as a member of the nuclear receptor superfamily with
unknown ligand (Taraviras et al., 1994
). Zinc-fingers are small
DNA-binding peptide motifs. These motifs can be used as modular
building blocks for the construction of larger protein domains that
recognize and bind to specific DNA sequences (Klug, 1999
). Steroids and
thyroid hormones, as well as vitamin D, retinoids, and some nutrient
metabolites (fatty acids, prostaglandins, farnesol metabolites) act
through binding to members of the zinc-finger containing superfamily of
nuclear hormone receptors. These receptor proteins bind directly to
specific DNA recognition sequences (hormone response elements) in the
promoter region of target genes to facilitate transcription. The
formation of several sets of heterodimers among family members as well
as cross-talk with other signaling systems results in an intricate
regulatory network with distinct particularities for each receptor type
(Meier, 1997
).
D. DNA-Binding Domain of Hepatocyte Nuclear Factor-6
HNF-6 is a liver-enriched transcription factor that contains a
single-cut domain and a novel type of homeodomain. Comparative trees of
mammalian, Drosophila, and C. elegans proteins
showed that HNF-6 defines a new class of homeodomain proteins called onecut class. It could be demonstrated that C. elegans
proteins of this class bind to HNF-6 DNA targets. Thus, depending on
their sequence, these targets determine for HNF-6 at least two modes of
DNA binding, which hinge on the homeodomain and on the linker that
separates it from the cut domain, and two modes of transcriptional stimulation, which hinge on the homeodomain (Lannoy et al., 1998
).
E. DNA-Binding Domain of CCAAT/Enhancer-Binding Proteins
Many transcription factors bind DNA to form dimeric (2:1)
protein-DNA complexes. Examples include basic region leucine zipper (bZIP) proteins and basic region helix-loop-helix zipper (bHLHZIP) proteins. These two families of transcription factors follow an assembly pathway in which two protein monomers bind DNA sequentially and form their dimerization interface while bound to DNA (Kohler et
al., 1999
). Dimerization of these transcription factors stabilizes the
protein-DNA complexes and can lead either to homodimers with the same
transcription factor or to heterodimers with other members of the same
family of transcription factors (Horiuchi et al., 1997
).
The bZIP family of proteins is one of the largest and most conserved
groups of eukaryotic transcription factors/repressors (Niu et al.,
1999
). These transcription factors use an atypically simple motif for
DNA recognition called the basic region, yet family members
discriminate differentially between target sites that differ only in
half-site spacing. Two such sites are the cAMP-response element (CRE)
and the AP-1 target site (Metallo and Schepartz, 1994
). The DNA-binding
motif of transcription factors belonging to the bZIP family is
bipartite, consisting of a dimerization interface termed "leucine
zipper" and a DNA contact surface termed the "basic region".
Specificity of DNA binding has been shown to be imparted by the basic
region (Agre et al., 1989
).
The CCAAT/enhancer-binding proteins (C/EBP
, C/EBP
, C/EBP
, and
C/EBP
) form a subfamily of bZIP transcription factors that display
sequence homology within the bZIP domain. The conserved basic region in
this subfamily contains two motifs that exhibit significant homology to
the bipartite nuclear localization signal promoting nuclear transport
of a bZIP transcription factor (Williams et al., 1997
).
Further important members of the bZIP family of transcription factors
are c-jun, c-fos (AP-1), and CREB. The molecular chaperone bZIP
enhancing factor (BEF) has been shown to increase DNA binding of
transcription factors that contain a basic region leucine zipper (bZIP)
DNA-binding domain. BEF stimulates DNA binding by recognizing the
unfolded leucine zipper and promoting the folding of bZIP monomers to
dimers. Antisense experiments indicate that BEF is required for
efficient transcriptional activation by bZIP proteins in vivo
(Virbasius et al., 1999
).
| |
III. Molecular Regulation of Liver Function |
|---|
|
|
|---|
A. Liver-Specific Gene Expression
The transcription rate of genes encoding liver-specific proteins
is distinctly higher in hepatocytes as compared with other cell types
(Powell et al., 1984
). The transcription of several hepatic genes is
activated during liver development and later modulated depending on
extracellular stimulation (Schmid and Schulz, 1990
; Cascio and Zaret,
1991
; Shiojori et al., 1991
). Experiments using a cDNA library from
mouse liver poly(A)+ RNA that was then differentially screened with
poly(A)+ RNA from liver and nonliver cells provided strong evidence
that the predominant control of liver-specific gene expression resides
at the level of transcription (Derman et al., 1981
; Aran et al., 1995
).
Clones proven to be liver-specific were picked and used as templates
for hybridization with radioactive RNA newly transcribed in vitro in
nuclei isolated from liver and nonliver tissues. The hybridization
signals obtained with RNA synthesized with liver nuclei were at least
10 times more intense than those obtained with nuclei from other
tissues. Because the cDNA clones represented an unbiased population of transcripts, the findings led to the conclusion that liver-specific gene expression is primarily a consequence of transcriptional regulation (Derman et al., 1981
).
Transient transfection assays in which the introduced gene does not
integrate into the genome have been instrumental in identifying the
regulatory sequences in DNA that confer liver-specific gene expression.
Analyses performed on a wide variety of genes that code for entirely
different proteins show shared regulatory sequences. Moreover,
characterization of the regulatory sequences of a number of genes has
shown that each gene contains a combination of some or all of the
liver-specific shared motifs (Benvenisty and Reshef, 1991
; Aran et al.,
1995
). It is this combination of cis-regulatory elements
rather than a single element that appears to be required for
liver-specific gene expression. Finally, these shared motifs bind
distinct cognate liver-enriched transcription factors and have aided in
isolating and characterizing these factors (for review see De Simone
and Cortese, 1991
; Lai and Darnell, 1991
; Aran et al., 1995
).
B. Liver-Enriched Transcription Factors
Six families of liver-enriched transcription factors have been
characterized so far: HNF-1, HNF-3, HNF-4, HNF-6, C/EBP, and D-binding
protein (DBP). The analysis of the tissue distribution of these
factors and the determination of their hierarchical relations have led
to the hypothesis that the cooperation of liver-enriched transcription
factors with the ubiquitous transactivating factors is necessary, and
possibly even sufficient, for the maintenance of liver-specific gene
transcription (Hayashi et al., 1999
).
HNFs are a heterogeneous class of evolutionarily conserved
transcription factors that contain several families of liver-enriched transcription factors that are required for cellular differentiation and metabolism (Duncan et al., 1998
). The liver-enriched transcription factor family containing the C/EBPs was formerly called HNF-2 and will
be reviewed separately along with the D-binding protein (DBP).
| |
IV. Hepatocyte Nuclear Factors |
|---|
|
|
|---|
The HNF-1, HNF-3, HNF-4, and HNF-6 families of transcription
factors contain several members. It should be noted that liver-enriched transcription factors are not exclusively expressed in the liver. For
example, HNF-1
, -3
, -3
, -3
, -4
, and -6 are also
expressed in pancreatic
-cells (Vaisse et al., 1997
). HNF-1
and
HNF-4
play there a critical role in normal pancreatic
-cell
function. Mutations in these liver-enriched transcription factors
result in two forms of maturity-onset diabetes of the young (MODY),
MODY3 and MODY1, respectively (Yamagata et al., 1996
; Vaisse et al., 1997
; Chevre et al., 1998
). There are many more examples of relevant extrahepatic functions of liver-enriched transcription factors, but it
is beyond the scope of this review to provide a complete summary of
those extrahepatic functions.
A. The Hepatocyte Nuclear Factor-1 Family
HNF-1 is a transcriptional regulator composed of HNF-1
and
HNF-1
hetero- and homodimers. These homeoproteins share identical DNA-binding domains but have different transcriptional activation properties (Kuo et al., 1991
; Song et al., 1998
).
The HNF-1
gene was assigned by somatic cell hybrids and recombinant
inbred strain mapping to mouse chromosome 5 near Bcd-1 and to human
chromosome 12 region q22-qter, revealing a different chromosomal region
for these two species (Kuo et al., 1990
). The HNF-1
gene was
assigned to human chromosome 17 and murine chromosome 11. These
chromosomal localizations differ from that of the HNF-1
gene,
indicating that both genes are not clustered on the genome (Bach et
al., 1991
).
HNF-1 is one of the most important transactivators of liver-specific
albumin transcription (Maire et al., 1989
). HNF-1 acts as an accessory
factor to enhance the inhibitory action of insulin on mouse
glucose-6-phosphatase gene transcription (Streeper et al., 1998
).
HNF-1
is also an accessory factor required for activation of
glucose-6-phosphatase gene transcription by glucocorticoids (Lin et
al., 1998
). Several lines of evidence point to a direct transactivation
of the mouse ferrochelatase promoter by HNF-1
in the liver (Muppala
et al., 2000
).
Plasma lipoprotein(a) concentrations are highly heritable and
predominantly determined by the liver-specific apolipoprotein(a) [apo(a)] gene. Elevated levels of lipoprotein(a) in the plasma are a
risk factor for coronary artery disease and stroke. Positive regulation
of transcription of the apo(a) gene is dependent on the binding of
HNF-1
to a regulatory element located downstream of the mRNA start
site (Wade et al., 1994
).
HNF-1
is able to repress the transcription of liver-specific genes
as demonstrated for the sucrose-isomaltase gene. Glucose represses
transcription of this gene in cooperation with three HNF-1-binding
sites in the sucrose-isomaltase promoter. Mutagenesis of the
HNF-1-binding sites showed that the two distal HNF-1-binding sites are
crucial for the glucose regulation of the sucrose-isomaltase gene
(Rodolosse et al., 1998
).
A number of genes that are predominantly expressed in the liver are
positively regulated by HNF-1
interacting with the respective cis-acting HNF-1-binding elements in the promoters of these
genes (see also Table 1).
|
Serum colloid osmotic pressure is believed to control hepatic output of
plasma proteins. Many plasma proteins that are secreted from the liver,
including albumin, have a HNF-1-binding site in their promoter. The
activity of HNF-1
in highly differentiated hepatoma cells was shown
to be modulated by a fluctuation in the level of oncotically active
macromolecules like dextran or albumin in the surrounding cell culture
medium. Higher oncotic pressures lead to a decrease in HNF-1
mRNA
levels (Pietrangelo and Shafritz, 1994
).
1. Dimerization Cofactor of Hepatocyte Nuclear Factor-1
and
Liver-Specific Gene Expression.
Interestingly, HNF-1
, but not
HNF-1
, is expressed in the liver. Under physiologic conditions as
well as in transfection experiments with HNF-1
and HNF-1
, stable
homodimer formation can be found in the liver, whereas in other organs,
heterodimers also are detected. From these data it was assumed that the
extent of heterodimerization may be regulated in a tissue-specific
manner. Furthermore, it could be shown that exclusive expression of
HNF-1
is associated with repression of a subset of
hepatocyte-specific genes in the dedifferentiated hepatocyte cell line
C2, in differentiated F9 cells, in somatic hybrids between hepatocytes
and fibroblasts, and in the lung (Mendel et al., 1991a
).
is unique among the vertebrate homeodomain-containing proteins
in that it dimerizes in the absence of its DNA recognition sequence
(Mendel et al., 1991b
(DCoH)
could be identified that displays a restricted tissue distribution and
does not bind to DNA, but, rather, selectively stabilizes HNF-1
homodimers. The formation of a stable tetrameric DCoH-HNF-1
complex
requires the dimerization domain of HNF-1
and does not change the
DNA-binding characteristics of HNF-1
, but enhances its
transcriptional activity. DCoH regulates the formation of transcriptionally active tetrameric complexes and thus may contribute to the developmental and tissue specificity of the complex (Mendel et
al., 1991b
is regarded as an
important regulator of the transcriptional network in liver development
and liver-specific gene expression.
The chromosomal localization of the genes for DCoH was assigned to
chromosomes 10 in both humans and mice by Southern blot analyses of
somatic cell hybrids (Milatovich et al., 1993
-carbinolamine dehydratase) is a bifunctional protein proposed to be involved in
entirely different biochemical functions. The protein coding region of
the gene is about 5 kb long and contains 4 exons. Within the
5'-flanking sequence, potential regulatory regions include consensus
binding sites for transcription factor Sp1, an AP-1, and several
AP-2-binding sites; however, the 5' upstream region lacks both a
proximal TATA and CAAT box promoter element (Thony et al., 1995B. The Hepatocyte Nuclear Factor-3 Subfamily
The mammalian HNF-3/fkh family consists of at least 30 distinct
members and is expressed in a variety of different cellular lineages
(Qian and Costa, 1995
). The HNF-3 gene subfamily is composed of three
proteins (
,
, and
) that mediate hepatocyte-enriched transcription of numerous genes whose expression is necessary for organ
function (Samadani and Costa, 1996
). All three transcription factors
share strong homology in the winged-helix/fork head DNA-binding domain
(region I) that overlaps with the nuclear localization signal (Qian and
Costa, 1995
). HNF-3
, -
, and -
are able to recognize the same
DNA sequence (Samadani and Costa, 1996
; Pani et al., 1992a
,b
). They
also possess two similar stretches of amino acids at the carboxyl
terminus (regions II and III) and a fourth segment of homology at the
amino terminus (region IV) (Pani et al., 1992a
,b
).
The HNF-3 proteins demonstrate homology with the Drosophila
homeotic gene fork head in regions I, II, and III, suggesting that
HNF-3 may be its mammalian homolog (Pani et al., 1992a
). Experiments
using site-directed mutagenesis within regions II and III (amino acids
361-458) of HNF-3
demonstrated their importance for
transactivation. In cotransfection assays with expression vectors that
produced different truncated HNF-3
proteins, amino-terminal sequences defined by conserved region IV also contributed to
transactivation, but region IV activity required the participation of
the region II-III domain (Pani et al., 1992a
).
HNF-3
and HNF-3
regulate gene expression in endoderm-derived
hepatocytes, and intestinal, pancreatic, and bronchiolar epithelium (Rausa et al., 1997
; Clevidence et al., 1998
). HNF-3
may also play
an important role in development and maintenance of urogenital tract
epithelial cells (Clevidence et al., 1998
; Kopachik et al., 1998
).
HNF-3
and HNF-3
are members of a large family of developmentally regulated transcription factors that participate in embryonic pattern
formation (Rausa et al., 1997
; Clevidence et al., 1998
).
Stimulation of HNF-3
gene transcription upon retinoic acid-induced
differentiation of mouse F9 embryonal carcinoma cells can give rise to
three distinct differentiated cell types; visceral endoderm, parietal
endoderm, and primitive endoderm, which indicates that HNF-3
may
play an important role in differentiation during primitive endoderm
formation, an extremely early event during murine embryogenesis (Jacob
et al., 1994
).
A number of liver-specific genes that are predominantly expressed in
the liver are positively regulated by HNF-3
, -
, or -
through
interaction with the respective cis-acting HNF-3-binding elements in the promoters of these genes (see also Table
2). In contrast, HNF-3 bound to the
HNF-3-binding site of the human aldolase B promoter completely
antagonizes transactivation of the liver-specific aldolase B gene by
HNF-1 and DBP (Gregori et al., 1993
).
|
|